Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Brief Genetics Report

The Role of Insulin Receptor Substrate-1 Gene (IRS1) in Type 2 Diabetes in Pima Indians

  1. Peter Kovacs,
  2. Robert L. Hanson,
  3. Yong-Ho Lee,
  4. Xiaolin Yang,
  5. Sayuko Kobes,
  6. Paska A. Permana,
  7. Clifton Bogardus and
  8. Leslie J. Baier
  1. From the Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona
  1. Address correspondence and reprint requests to Leslie J. Baier, PhD, Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 4212 N. 16th St., Phoenix, AZ 85016. E-mail: lbaier{at}phx.niddk.nih.gov
Diabetes 2003 Dec; 52(12): 3005-3009. https://doi.org/10.2337/diabetes.52.12.3005
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Genetic variants detected in the IRS1 gene and flanking regions, their position, and frequency of minor allele. SNPs in italics were genotyped as the representative SNP for their LD group. Positions of variants are based on the genomic contig AC010735 (GenBank). D′ representing the degree of LD for genotyped SNPs was: 0.84 between −2223C/T and −7120G/A; 0.89 between −446G/A and −7120G/A; −0.66 between Ala804 and −7120G/A; 1.00 between −446G/A and −2223C/T; −1.00 between Ala804 and −2223C/T; and −1.00 between Ala804 and −446G/A. Allele frequencies for variants representative of LD groups were calculated from genotypes in 937 subjects; otherwise, 24 DNA samples were considered for estimating allele frequencies. D′ is expressed as a proportion of the maximum possible given the allele frequencies and the direction of association. D′ was calculated so that a positive value represents association among the more common alleles at each SNP, whereas a negative value represents association among the more common allele at one SNP and the less common allele at the other.

Tables

  • Figures
  • TABLE 1

    Association of IRS1 variants with type 2 diabetes in Pima Indians

    Homozygote-common alleleHeterozygoteHomozygote minor alleleOdds ratio (95% CI)P
    −7120G/A
     GenotypeG/GG/AA/A
     Diabetic326 (61)182 (34)30 (6)
     Nondiabetic210 (66)96 (31)10 (3)0.70 (0.54–0.91)0.01
    −2223C/T
     GenotypeC/CC/TT/T
     Diabetic413 (77)119 (22)7 (1)
     Nondiabetic255 (79)63 (20)4 (1)0.81 (0.56–1.17)0.26
    −446G/A
     GenotypeG/GG/AA/A
     Diabetic363 (65)182 (33)14 (2)
     Nondiabetic237 (72)84 (26)6 (2)0.66 (0.48–0.90)0.01
    Ala804 (GCG/GCA)
     GenotypeG/GG/AA/A
     Diabetic201 (34)299 (51)86 (15)
     Nondiabetic91 (27)193 (56)59 (17)1.29 (1.02–1.63)0.04
    • Data are n (%). The odds ratio is given for a one-allele difference in the number of common alleles, adjusted for age and sex, and calculated by binomial generalized estimating equations that account for family membership; the P value is that for the null hypothesis of no difference in allele frequency between diabetic and nondiabetic individuals calculated by the Cochran-Armitage test for a linear trend in proportions.

  • TABLE 2

    Common haplotypes at IRS1 and their association with type 2 diabetes in Pima Indians

    HaplotypeCompositionFrequencyFrequency (diabetes)Frequency (nondiabetic)Odds ratio (95% CI)P
    IG_C_G_A0.390.380.420.78 (0.62–0.97)0.15
    IIG_C_G_G0.380.380.380.97 (0.78–1.20)1.00
    IIIA_T_A_G0.100.100.101.00 (0.71–1.41)1.00
    IVA_C_A_G0.050.060.032.44 (1.46–4.06)<0.01
    VA_C_G_A0.030.030.041.16 (0.65–2.07)0.99
    VIA_C_G_G0.020.020.021.75 (0.79–3.92)0.67
    VIIG_T_A_G0.010.020.012.44 (1.04–5.71)0.22
    • A modification of the zero-recombinant haplotyping method was used to assess association between traits of interest and haplotypes of the four IRS1 SNPs (23,24). Haplotypes are defined by the composition of alleles at each SNP in following order: −7120G/A_−2223C/T_−446G/A_Ala804. Odds ratios are calculated adjusted for age and sex for a difference of one in the number of the relevant haplotype using a binomial generalized estimating equation model that accounts for family membership; P values are adjusted for the multiple comparisons involved in analysis of 7 different haplotypes using the Bonferroni correction [corrected P value = 1 − (1 − P)6].

  • TABLE 3

    Association of IRS1 variants with diabetes-related traits in Pima Indians with normal glucose tolerance

    Genotype−7120G/A
    P−2223C/T
    P−446G/A
    PAla804 (GCG/GCA)
    P
    G/GG/A + A/AC/CC/T + T/TG/GG/A + A/AG/GG/AA/A
    n1437617552164667013035
    Age (years)27 ± 127 ± 1—27 ± 128 ± 1—27 ± 127 ± 1—27 ± 127 ± 126 ± 1—
    Percent body fat32 ± 135 ± 10.9732 ± 133 ± 10.9633 ± 133 ± 10.7334 ± 133 ± 130 ± 20.80
    Fasting plasma glucose (mg/dl)91 ± 192 ± 10.8592 ± 192 ± 10.9892 ± 192 ± 10.8093 ± 191 ± 189 ± 10.09
    2-h plasma glucose (mg/dl)125 ± 3130 ± 30.54127 ± 2126 ± 40.74126 ± 3127 ± 30.99133 ± 3127 ± 3109 ± 50.01
    Log10 fasting plasma insulin (μU/ml)1.55 ± 0.021.59 ± 0.020.701.55 ± 0.021.58 ± 0.030.761.55 ± 0.021.57 ± 0.030.881.60 ± 0.031.56 ± 0.021.49 ± 0.060.06
    Log10 2-h plasma insulin (μU/ml)2.18 ± 0.032.23 ± 0.040.762.20 ± 0.032.21 ± 0.040.892.19 ± 0.032.21 ± 0.040.992.30 ± 0.042.17 ± 0.032.07 ± 0.080.03
    Basal glucose turnover (mg · kg EMBS−1 · min−1)1.93 ± 0.021.93 ± 0.030.781.92 ± 0.021.91 ± 0.030.861.92 ± 0.021.92 ± 0.030.791.93 ± 0.031.90 ± 0.021.93 ± 0.040.98
    Glucose disposal for low dose insulin clamp (mg · kg EMBS−1 · min−1)2.57 ± 0.082.53 ± 0.110.672.57 ± 0.072.52 ± 0.120.412.56 ± 0.072.58 ± 0.120.502.39 ± 0.092.59 ± 0.092.91 ± 0.200.04
    Glucose disposal for high dose insulin clamp (mg · kg EMBS−1 · min−1)8.62 ± 0.188.52 ± 0.220.948.64 ± 0.178.44 ± 0.280.808.57 ± 0.168.69 ± 0.270.558.00 ± 0.218.76 ± 0.199.04 ± 0.400.04
    • Data are given as means ± SE. P values were calculated after adjusting for age, sex, and nuclear family membership for the variable percent body fat; and age, sex, percent body fat, and nuclear family membership for the variables 2-h plasma glucose, 2-h plasma insulin, and log10 glucose disposal for the low- and high-dose insulin clamps. EMBS, estimated metabolic body size; due to the low frequency of the rare alleles for −7120G/A, −2223C/T and −446G/A variants, for statistical analysis the homozygotes for each rare allele were combined with the heterozygotes; therefore, only a dominant effect on risk has been tested for the rare alleles.

PreviousNext
Back to top

In this Issue

December 2003, 52(12)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Role of Insulin Receptor Substrate-1 Gene (IRS1) in Type 2 Diabetes in Pima Indians
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Role of Insulin Receptor Substrate-1 Gene (IRS1) in Type 2 Diabetes in Pima Indians
Peter Kovacs, Robert L. Hanson, Yong-Ho Lee, Xiaolin Yang, Sayuko Kobes, Paska A. Permana, Clifton Bogardus, Leslie J. Baier
Diabetes Dec 2003, 52 (12) 3005-3009; DOI: 10.2337/diabetes.52.12.3005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

The Role of Insulin Receptor Substrate-1 Gene (IRS1) in Type 2 Diabetes in Pima Indians
Peter Kovacs, Robert L. Hanson, Yong-Ho Lee, Xiaolin Yang, Sayuko Kobes, Paska A. Permana, Clifton Bogardus, Leslie J. Baier
Diabetes Dec 2003, 52 (12) 3005-3009; DOI: 10.2337/diabetes.52.12.3005
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Genetic Variation at the ACE Gene Is Associated With Persistent Microalbuminuria and Severe Nephropathy in Type 1 Diabetes
  • Is Puberty an Accelerator of Type 1 Diabetes in IL6-174CC Females?
  • Association of the Diabetes Gene Calpain-10 With Subclinical Atherosclerosis
Show more Brief Genetics Report

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.